Protocol design does not struggle in the protocol. It struggles in the transition to trial, when assumptions embedded in the ...
FDA proof-of-concept trials with AstraZeneca and Amgen validate continuous data transmission and signal detection, setting ...
GeneTAC® small molecule designed to selectively reduce transcription of the mutant DMPK allele and address the underlying cause of DM1CARLSBAD, ...
How AI Is Transforming Trial Design Artificial intelligence has become an integral part of the vision for clinical research ...
ASCO 2026 marked an important transition in oncology. Rather than showcasing isolated advances, the meeting demonstrated how ...
After a double whammy blow, Cynata is “actively reviewing” alternative uses for its Cymerus platform technology. ... Read ...
The trial is real, and it is a meaningful step. It is also, by design, small, tightly controlled, and years away from ...
The rarity of sarcoma complicates clinical trial design and biomarker-driven treatment, explains Alexander Spira, MD, PhD, ...
Reliable clinical trial data starts in Phase 1. Learn how early quality signals protect safety and guide confident sponsor decisions.
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...
The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...
Morning Overview on MSN
The first US trials of gene-edited pig kidneys in patients are set to begin
Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results